<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03196193</url>
  </required_header>
  <id_info>
    <org_study_id>T.CR.I.AP.16.4</org_study_id>
    <nct_id>NCT03196193</nct_id>
  </id_info>
  <brief_title>CM Asia Nail With AS2 Without AS2 （AS2 Study）</brief_title>
  <official_title>Randomized Controlled Study Comparing Zimmer Natural Nail System Cephalomedullary Asia Nail With Anterior Support Screw (AS2) Versus Conventional Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare reduction positon maintenance rate at 3 weeks&#xD;
      post-operatively between patients operated with Anterior Support Screw (AS2) and without AS2&#xD;
      technique in RCT setting. Total 240 cases(each arm 120 cases) will be enrolled at maximum&#xD;
      15sites, total study duration is 22months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective： To compare fracture reduction maintenance rate at 2-3weeks post-operatively&#xD;
      between patients operated with AS2 (investigational group) and patients operated without AS2&#xD;
      (Control group) using same implant system (ZNN CM Asia, Zimmer Biomet).&#xD;
&#xD;
      Endpoint： Primary： The rate of reduction position maintenance at 2-3 weeks post-operatively.&#xD;
      Secondary： Surgery time / fracture type / postoperative reduction position / CT assessment /&#xD;
      Safety information&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 21, 2017</start_date>
  <completion_date type="Actual">April 9, 2020</completion_date>
  <primary_completion_date type="Actual">April 2, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>At surgery, intervention group using ZNN CM Asia with AS2 technique. At surgery, conventional group using ZNN CM Asia without AS2 technique.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>(Investigational group) or ZNN CM Asia without AS2 technique (Control group). The randomization scheme is based on equal numbers per group. The randomization will occur via a random number generator (computer) using a blocked randomization procedure. The block size will not be disclosed to the sites, and the doctor or other health care professional will not have influence on the randomization scheme. Sealed opaque envelopes, which will be prepared based on predetermined randomization assignment, will be provided to each study site before study initiation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patient With and Without Excessive Lag Screw Sliding Distance</measure>
    <time_frame>Postoperative 2-3 week</time_frame>
    <description>Number of patient was counted based on CT measurement results. Relative position of lag screw between CT images taken at both immediate and 2-3 weeks postoperatively was measured and recorded in value (e.g., 1.5 mm). This was called as &quot;lag screw sliding distance&quot;. Four millimeter was set as threshold to define success and failure. Less than 4mm of lag screw sliding distance was recognized as Success and equal to or more than 4mm of lag screw sliding distance was recognized as Failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgery Time</measure>
    <time_frame>Intraoperative, an average of 1 hour</time_frame>
    <description>Surgery time from skin incision to closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Image Assessment Using Computed Tomography (CT)</measure>
    <time_frame>2-3 weeks postoperatively</time_frame>
    <description>Number of patient was counted based on CT measurement results. When the fracture reduction position achieved at surgery was maintained at 2 to 3 weeks, then the patient was categorized as success (Reduction position maintained). On the other hand, patient was categorized as failure (Reduction position changed) in the case that the fracture reduction position was changed.&#xD;
Fracture repair position was categorized into three; &quot;Anterior&quot;, &quot;Neutral&quot; or &quot;Posterior&quot; based on relative position of proximal bone fragment and distal bone fragment.&#xD;
This analysis only includes patients whose fracture reduction position at immediate postoperative CT was either &quot;Anterior&quot; or &quot;Neutral&quot;.&#xD;
If both immediate and 2-3 weeks postoperative CT images show same fracture reduction position (example: &quot;Anterior&quot; at immediate postoperatively &amp; &quot;Anterior&quot; at 2-3 weeks postoperatively), then the patient was recognized as Success (Reduction position maintained).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative Safety</measure>
    <time_frame>Intraoperative</time_frame>
    <description>This is to evaluate whether any adverse events specific to insert additional screw for AS2 technique were occurred.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Trochanteric Fracture of Femur</condition>
  <arm_group>
    <arm_group_label>ZNN CM Asia with AS2 technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open Reduction and Internal Fixation with AS2 Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail.&#xD;
Bone fragment will be stabilized by additional screw fixation (Anterior Support Screw).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ZNN CM Asia without AS2 technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail without additional screw fixation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Reduction and Internal Fixation</intervention_name>
    <description>Fractured bone fragments are reduced and stabilized by intramedullary nail.</description>
    <arm_group_label>ZNN CM Asia with AS2 technique</arm_group_label>
    <arm_group_label>ZNN CM Asia without AS2 technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ZNN CM Asia</intervention_name>
    <description>Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.</description>
    <arm_group_label>ZNN CM Asia with AS2 technique</arm_group_label>
    <arm_group_label>ZNN CM Asia without AS2 technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anterior Support Screw</intervention_name>
    <description>Experimental group will receive insertion of ACE 4.5/5.0mm cannulated lag-screw anteriorly to Zimmer Natural Nail CM Asia Lag-screw.</description>
    <arm_group_label>ZNN CM Asia with AS2 technique</arm_group_label>
    <other_name>ACE 4.5/5.0mm cannulated lag-screw</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        In order to be eligible to participate in this study, a subject must meet all of the&#xD;
        following criteria.&#xD;
&#xD;
          -  Eligible for intramedullary nailing.&#xD;
&#xD;
          -  Fracture type is classified as 3-partB or 4-part fracture in 3D-CT (Three Dimensional&#xD;
             Computed Tomography) classification (Nakano), and combination with a subtype P in&#xD;
             lateral classification (Ikuta) at preoperative CT (Computed Tomography) assessment.(In&#xD;
             the case of classified in radiograph (X-ray) at preoperative: Classified as Type 4 or&#xD;
             Type 5 in Jensen classification, and combination of subtype P in lateral&#xD;
             classification (Ikuta))&#xD;
&#xD;
          -  Japanese Male or female&#xD;
&#xD;
          -  &gt; 20 years of age&#xD;
&#xD;
          -  Primary closed intertrochanteric fracture of the femur&#xD;
&#xD;
          -  Subjects willing to return for follow-up evaluations.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A potential subject who meets any of the following criteria will be excluded from&#xD;
        participation in this study.&#xD;
&#xD;
          -  Patient who cannot take CT image within 3 days and 2-3weeks after surgery.&#xD;
&#xD;
          -  Uncooperative patient or patient with neurologic disorders who are incapable of&#xD;
             following directions.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Takashi Maehara, MD, Ph. D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kagawa Rosai Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kure Kyosai Hospital</name>
      <address>
        <city>Kure</city>
        <state>Hiroshima</state>
        <zip>737-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toyooka Hospital</name>
      <address>
        <city>Toyooka</city>
        <state>Hyogo</state>
        <zip>668-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kasugai Municipal Hospital</name>
      <address>
        <city>Aichi</city>
        <state>Kasugai</state>
        <zip>486-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hoshigaoka Medical Center</name>
      <address>
        <city>Hirakata</city>
        <state>Osaka</state>
        <zip>573-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Numazu City Hospital</name>
      <address>
        <city>Numazu</city>
        <state>Shizuoka</state>
        <zip>410-0302</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saiseikai Takaoka Hospital</name>
      <address>
        <city>Takaoka</city>
        <state>Toyama</state>
        <zip>933-8525</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyushu Central Hospital</name>
      <address>
        <city>Fukuoka</city>
        <zip>815-8588</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saiseikai Kumamoto Hospital</name>
      <address>
        <city>Kumamoto</city>
        <zip>861-4193</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niigata Central Hospital</name>
      <address>
        <city>Niigata</city>
        <zip>950-8556</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Okayama Red Cross Hospital</name>
      <address>
        <city>Okayama</city>
        <zip>700-8607</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Okayama Rosai Hospital</name>
      <address>
        <city>Okayama</city>
        <zip>702-8055</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saga Pref. Medical Centre Koseikan</name>
      <address>
        <city>Saga</city>
        <zip>840-8571</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 28, 2017</study_first_submitted>
  <study_first_submitted_qc>June 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2017</study_first_posted>
  <results_first_submitted>August 6, 2020</results_first_submitted>
  <results_first_submitted_qc>September 8, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 29, 2020</results_first_posted>
  <last_update_submitted>September 8, 2020</last_update_submitted>
  <last_update_submitted_qc>September 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hip Fractures</mesh_term>
    <mesh_term>Femoral Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 5, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/93/NCT03196193/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ZNN CM Asia With AS2 Technique</title>
          <description>Open Reduction and Internal Fixation with AS2 Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail.&#xD;
Bone fragment will be stabilized by additional screw fixation (Anterior Support Screw).&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.&#xD;
Anterior Support Screw: Experimental group will receive insertion of ACE 4.5/5.0mm cannulated lag-screw anteriorly to Zimmer Natural Nail CM Asia Lag-screw.</description>
        </group>
        <group group_id="P2">
          <title>ZNN CM Asia Without AS2 Technique</title>
          <description>Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail without additional screw fixation.&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="121"/>
                <participants group_id="P2" count="119"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="118"/>
                <participants group_id="P2" count="119"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Computed Tomography (CT) data missing</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ZNN CM Asia With AS2 Technique</title>
          <description>Open Reduction and Internal Fixation with AS2 Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail.&#xD;
Bone fragment will be stabilized by additional screw fixation (Anterior Support Screw).&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.&#xD;
Anterior Support Screw: Experimental group will receive insertion of ACE 4.5/5.0mm cannulated lag-screw anteriorly to Zimmer Natural Nail CM Asia Lag-screw.</description>
        </group>
        <group group_id="B2">
          <title>ZNN CM Asia Without AS2 Technique</title>
          <description>Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail without additional screw fixation.&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="118"/>
            <count group_id="B2" value="119"/>
            <count group_id="B3" value="237"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="118"/>
                    <count group_id="B2" value="119"/>
                    <count group_id="B3" value="237"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85.9" spread="8.9"/>
                    <measurement group_id="B2" value="86.7" spread="7.9"/>
                    <measurement group_id="B3" value="86.3" spread="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="118"/>
                    <count group_id="B2" value="119"/>
                    <count group_id="B3" value="237"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="103"/>
                    <measurement group_id="B2" value="97"/>
                    <measurement group_id="B3" value="200"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Japan</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="118"/>
                    <count group_id="B2" value="119"/>
                    <count group_id="B3" value="237"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="118"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="118"/>
                    <count group_id="B2" value="119"/>
                    <count group_id="B3" value="237"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="148.9" spread="8.8"/>
                    <measurement group_id="B2" value="150.0" spread="9.0"/>
                    <measurement group_id="B3" value="149.4" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="118"/>
                    <count group_id="B2" value="119"/>
                    <count group_id="B3" value="237"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.3" spread="9.8"/>
                    <measurement group_id="B2" value="46.2" spread="9.3"/>
                    <measurement group_id="B3" value="45.8" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patient With and Without Excessive Lag Screw Sliding Distance</title>
        <description>Number of patient was counted based on CT measurement results. Relative position of lag screw between CT images taken at both immediate and 2-3 weeks postoperatively was measured and recorded in value (e.g., 1.5 mm). This was called as &quot;lag screw sliding distance&quot;. Four millimeter was set as threshold to define success and failure. Less than 4mm of lag screw sliding distance was recognized as Success and equal to or more than 4mm of lag screw sliding distance was recognized as Failure.</description>
        <time_frame>Postoperative 2-3 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ZNN CM Asia With AS2 Technique</title>
            <description>Open Reduction and Internal Fixation with AS2 Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail.&#xD;
Bone fragment will be stabilized by additional screw fixation (Anterior Support Screw).&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.&#xD;
Anterior Support Screw: Experimental group will receive insertion of ACE 4.5/5.0mm cannulated lag-screw anteriorly to Zimmer Natural Nail CM Asia Lag-screw.</description>
          </group>
          <group group_id="O2">
            <title>ZNN CM Asia Without AS2 Technique</title>
            <description>Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail without additional screw fixation.&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient With and Without Excessive Lag Screw Sliding Distance</title>
          <description>Number of patient was counted based on CT measurement results. Relative position of lag screw between CT images taken at both immediate and 2-3 weeks postoperatively was measured and recorded in value (e.g., 1.5 mm). This was called as &quot;lag screw sliding distance&quot;. Four millimeter was set as threshold to define success and failure. Less than 4mm of lag screw sliding distance was recognized as Success and equal to or more than 4mm of lag screw sliding distance was recognized as Failure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Success (lag screw sliding distance &lt;4mm)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="109"/>
                    <measurement group_id="O2" value="97"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Failure (lag screw sliding distance &gt;=4mm)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Surgery Time</title>
        <description>Surgery time from skin incision to closure</description>
        <time_frame>Intraoperative, an average of 1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ZNN CM Asia With AS2 Technique</title>
            <description>Open Reduction and Internal Fixation with AS2 Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail.&#xD;
Bone fragment will be stabilized by additional screw fixation (Anterior Support Screw).&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.&#xD;
Anterior Support Screw: Experimental group will receive insertion of ACE 4.5/5.0mm cannulated lag-screw anteriorly to Zimmer Natural Nail CM Asia Lag-screw.</description>
          </group>
          <group group_id="O2">
            <title>ZNN CM Asia Without AS2 Technique</title>
            <description>Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail without additional screw fixation.&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.</description>
          </group>
        </group_list>
        <measure>
          <title>Surgery Time</title>
          <description>Surgery time from skin incision to closure</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.2" spread="21.8"/>
                    <measurement group_id="O2" value="59.8" spread="20.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Image Assessment Using Computed Tomography (CT)</title>
        <description>Number of patient was counted based on CT measurement results. When the fracture reduction position achieved at surgery was maintained at 2 to 3 weeks, then the patient was categorized as success (Reduction position maintained). On the other hand, patient was categorized as failure (Reduction position changed) in the case that the fracture reduction position was changed.&#xD;
Fracture repair position was categorized into three; &quot;Anterior&quot;, &quot;Neutral&quot; or &quot;Posterior&quot; based on relative position of proximal bone fragment and distal bone fragment.&#xD;
This analysis only includes patients whose fracture reduction position at immediate postoperative CT was either &quot;Anterior&quot; or &quot;Neutral&quot;.&#xD;
If both immediate and 2-3 weeks postoperative CT images show same fracture reduction position (example: &quot;Anterior&quot; at immediate postoperatively &amp; &quot;Anterior&quot; at 2-3 weeks postoperatively), then the patient was recognized as Success (Reduction position maintained).</description>
        <time_frame>2-3 weeks postoperatively</time_frame>
        <population>Participants, whose immediate postoperative reduction position is assessed as either &quot;Anterior&quot; or &quot;Neutral&quot;, were eligible.&#xD;
Eight patients in ZNN CM Asia with AS2 technique group and 6 patients in ZNN CM Asia without AS2 technique group were excluded from this analysis (their immediate postoperative reduction position was &quot;Posterior&quot;.)</population>
        <group_list>
          <group group_id="O1">
            <title>ZNN CM Asia With AS2 Technique</title>
            <description>Open Reduction and Internal Fixation with AS2 Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail.&#xD;
Bone fragment will be stabilized by additional screw fixation (Anterior Support Screw).&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.&#xD;
Anterior Support Screw: Experimental group will receive insertion of ACE 4.5/5.0mm cannulated lag-screw anteriorly to Zimmer Natural Nail CM Asia Lag-screw.</description>
          </group>
          <group group_id="O2">
            <title>ZNN CM Asia Without AS2 Technique</title>
            <description>Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail without additional screw fixation.&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.</description>
          </group>
        </group_list>
        <measure>
          <title>Image Assessment Using Computed Tomography (CT)</title>
          <description>Number of patient was counted based on CT measurement results. When the fracture reduction position achieved at surgery was maintained at 2 to 3 weeks, then the patient was categorized as success (Reduction position maintained). On the other hand, patient was categorized as failure (Reduction position changed) in the case that the fracture reduction position was changed.&#xD;
Fracture repair position was categorized into three; &quot;Anterior&quot;, &quot;Neutral&quot; or &quot;Posterior&quot; based on relative position of proximal bone fragment and distal bone fragment.&#xD;
This analysis only includes patients whose fracture reduction position at immediate postoperative CT was either &quot;Anterior&quot; or &quot;Neutral&quot;.&#xD;
If both immediate and 2-3 weeks postoperative CT images show same fracture reduction position (example: &quot;Anterior&quot; at immediate postoperatively &amp; &quot;Anterior&quot; at 2-3 weeks postoperatively), then the patient was recognized as Success (Reduction position maintained).</description>
          <population>Participants, whose immediate postoperative reduction position is assessed as either &quot;Anterior&quot; or &quot;Neutral&quot;, were eligible.&#xD;
Eight patients in ZNN CM Asia with AS2 technique group and 6 patients in ZNN CM Asia without AS2 technique group were excluded from this analysis (their immediate postoperative reduction position was &quot;Posterior&quot;.)</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="110"/>
                <count group_id="O2" value="113"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Reduction position maintained</title>
                  <measurement_list>
                    <measurement group_id="O1" value="104"/>
                    <measurement group_id="O2" value="92"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Reduction position changed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraoperative Safety</title>
        <description>This is to evaluate whether any adverse events specific to insert additional screw for AS2 technique were occurred.</description>
        <time_frame>Intraoperative</time_frame>
        <population>Intent-to-treat group</population>
        <group_list>
          <group group_id="O1">
            <title>ZNN CM Asia With AS2 Technique</title>
            <description>Open Reduction and Internal Fixation with AS2 Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail.&#xD;
Bone fragment will be stabilized by additional screw fixation (Anterior Support Screw).&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.&#xD;
Anterior Support Screw: Experimental group will receive insertion of ACE 4.5/5.0mm cannulated lag-screw anteriorly to Zimmer Natural Nail CM Asia Lag-screw.</description>
          </group>
          <group group_id="O2">
            <title>ZNN CM Asia Without AS2 Technique</title>
            <description>Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail without additional screw fixation.&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.</description>
          </group>
        </group_list>
        <measure>
          <title>Intraoperative Safety</title>
          <description>This is to evaluate whether any adverse events specific to insert additional screw for AS2 technique were occurred.</description>
          <population>Intent-to-treat group</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="121"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>No adverse event</title>
                  <measurement_list>
                    <measurement group_id="O1" value="121"/>
                    <measurement group_id="O2" value="119"/>
                  </measurement_list>
                </category>
                <category>
                  <title>adverse event</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 weeks after surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ZNN CM Asia With AS2 Technique</title>
          <description>Open Reduction and Internal Fixation with AS2 Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail.&#xD;
Bone fragment will be stabilized by additional screw fixation (Anterior Support Screw).&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.&#xD;
Anterior Support Screw: Experimental group will receive insertion of ACE 4.5/5.0mm cannulated lag-screw anteriorly to Zimmer Natural Nail CM Asia Lag-screw.</description>
        </group>
        <group group_id="E2">
          <title>ZNN CM Asia Without AS2 Technique</title>
          <description>Trochanteric Fracture treated by Open Reduction and Internal Fixation using with ZNN CM Asia nail without additional screw fixation.&#xD;
Open Reduction and Internal Fixation: Fractured bone fragments are reduced and stabilized by intramedullary nail.&#xD;
ZNN CM Asia: Reduced bone fragments are to be stabilized by Zimmer Natural Nail CM Asia System.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="119"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="119"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Cut-out</sub_title>
                <description>Proximal fracture fragment was dislodged after surgery and required reoperation to hemi hip replacement surgery.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="119"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="119"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Manager of Clinical Affairs</name_or_title>
      <organization>Zimmer Biomet G.K.</organization>
      <phone>+81-3-6402-6610</phone>
      <email>takahito.nakai@zimmerbiomet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

